Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | INMT | O95050 | 3/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.32 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.31 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22106039 | 0.98 | USP2 (0.41) | INMTUSP2HRH4ABCB11CHRM2 | |
| SCHEMBL58331 | 0.93 | INMT (0.39) | INMTUSP2ABCB11CHRM2MAOA | |
| SCHEMBL14753506 | 0.93 | INMT (0.43) | INMTUSP2HRH4ABCB11CHRM2 | |
| SCHEMBL22106040 | 0.91 | INMT (0.47) | INMTUSP2HRH4ABCB11CHRM2 | |
| Hydrochloric Acid SCHEMBL31500435 | 0.91 | INMT (0.38) | INMTUSP2ABCB11CHRM2MAOA | |
| SCHEMBL15038753 | 0.91 | NOS1 (0.35) | INMTUSP2 | |
| SCHEMBL14753505 | 0.84 | INMT (0.39) | INMTUSP2HRH4ABCB11CHRM2 | |
| Acetic Acid SCHEMBL20424809 | 0.83 | INMT (0.40) | INMTUSP2CHRM2MAOA | |
| Acetic Acid SCHEMBL23577688 | 0.81 | INMT (0.39) | INMTUSP2CHRM2MAOA | |
| SCHEMBL22186981 | 0.81 | INMT (0.56) | INMTUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11380852-B2 | N-type dopants for efficient solar cells | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-07-05 | — | — | US | disclosed |
| US-20200194686-A1 | N-TYPE DOPANTS FOR EFFICIENT SOLAR CELLS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2020-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11380852-B2 | N-type dopants for efficient solar cells | DCTD, ALKBH2, METTL3 | INMT 29/4885USP2 3210/4885HRH4 4133/4885 |
| US-20200194686-A1 | N-TYPE DOPANTS FOR EFFICIENT SOLAR CELLS | DCTD, ALKBH2, METTL3 | INMT 29/4885USP2 3210/4885HRH4 4133/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.